US Patent 10584114 Inhibitors of RET
Patent 10584114 was granted and assigned to Blueprint Medicines on March, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10584114 Inhibitors of RET
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
